GET DAILY SIGNALSWhy Is Banco Macro (BMA) Stock Down -11.63% Today?
Key Takeaways
- Banco Macro (BMA) shares fell roughly 11.63% to about $58.36, down from a prior close of $66.04.
- The primary catalyst was contagion from Brazil's unexpected presidential runoff result, which triggered a broad selloff across Latin American equities.
- Argentine banking and energy ADRs broadly declined in sympathy as regional risk sentiment soured.
- The move reflects elevated emerging-market risk aversion rather than any company-specific earnings or operational news.
- Traders are watching whether the regional selloff stabilizes and how Argentine macro indicators respond in the coming sessions.
- For more detail on this stock's valuation and technicals, explore Price Targets, Earnings, and Forecast.
- To track market-tested algorithmic strategies across thousands of tickers, visit Trending AI Robots.
Opening Summary
BMA, the New York-listed American Depositary Receipt of Banco Macro S.A., one of Argentina's largest private banks headquartered in Buenos Aires, is trading sharply lower on Monday. The stock fell approximately 11.63% to around $58.36, down from a prior-session close of $66.04. The decline was driven almost entirely by a regional risk-off wave sparked by the surprise outcome of Brazil's presidential runoff election, which pressured Brazilian and Argentine assets alike rather than by any change in the bank's own fundamentals.
Brazil's Election Result Sparks Regional Contagion
The dominant catalyst behind Monday's decline was political and macro, not company-specific. Brazil's runoff vote delivered an unexpected outcome that markets had not fully priced in, reversing bets that had been built around a potential shift toward tighter fiscal policy in Latin America's largest economy. The result triggered steep losses in Brazilian equities, a slide in the Brazilian real, and a broad repricing of risk across the region.
Argentine ADRs, which frequently trade in sympathy with Brazilian assets due to shared emerging-market dynamics, were caught in the downdraft. BMA fell alongside banking and energy peers as investors reduced exposure to the entire Latin American complex. The selloff underscores how Argentine equities often act as a high-beta proxy for regional sentiment even when domestic news is quiet.
Sector and Peer Sympathy Selling
The decline in BMA was part of a broader move across Argentine financials. Peers including GGAL (Grupo Financiero Galicia) and BBAR (BBVA Argentina) also traded lower, as did energy and e-commerce names with regional exposure such as YPF and MELI (Mercado Libre). The synchronized nature of the move indicates a macro-driven, sector-wide de-risking rather than an idiosyncratic reaction to any single bank's news.
Market Context and Trading Activity
Trading activity reflected elevated urgency, with volume running well above recent averages as investors repositioned across Latin American financials. The move pushed BMA back toward the lower end of its recent trading range, and the stock remains well below both its 50-day and 200-day moving averages, reinforcing a bearish technical backdrop that predates Monday's decline. Broader Argentine and Brazilian equity benchmarks moved in the same direction, confirming that the drop was not isolated to this single issuer.
What Comes Next for BMA
Investors will now watch whether the regional selloff stabilizes or extends as markets digest the full policy implications of Brazil's election outcome. Argentina's own macro backdrop, including inflation trends, the peso, and country risk, will remain key variables for BMA given the bank's direct exposure to the domestic economy. Upcoming earnings and any signals on lending growth, net interest margins, and asset quality will also shape the stock's path. As with any emerging-market financial, currency volatility and political uncertainty remain the principal risks to the near-term outlook.
Trending AI Robots
Tickeron's Trending AI Robots page highlights a curated selection of algorithmic trading bots that are performing strongly under current market conditions. Tickeron offers hundreds of AI trading bots covering thousands of tickers, with strategies that vary by timeframe, performance metrics, and traded symbols. Only the top performers in the prevailing environment are featured. Explore the page to see which strategies are currently leading.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
BMA's RSI Oscillator ascending out of oversold territory
The RSI Oscillator for BMA moved out of oversold territory on October 15, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 28 similar instances when the indicator left oversold territory. In 26 of the 28 cases the stock moved higher. This puts the odds of a move higher at 90%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 47 of 56 cases where BMA's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 84%.
The Moving Average Convergence Divergence (MACD) for BMA just turned positive on October 13, 2026. Looking at past instances where BMA's MACD turned positive, the stock continued to rise in 36 of 42 cases over the following month. The odds of a continued upward trend are 86%.
Following a +2.24% 3-day Advance, the price is estimated to grow further. Considering data from situations where BMA advanced for three days, in 235 of 294 cases, the price rose further within the following month. The odds of a continued upward trend are 80%.
BMA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on October 26, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on BMA as a result. In 68 of 88 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 77%.
The 50-day moving average for BMA moved below the 200-day moving average on September 23, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where BMA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 78%.
The Aroon Indicator for BMA entered a downward trend on October 26, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron SMR rating for this company is 1 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 2 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 56, placing this stock better than average.
The Tickeron Valuation Rating of 15 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: BMA's P/B Ratio (0.001) is slightly lower than the industry average of (1.272). P/E Ratio (0.001) is within average values for comparable stocks, (13.289). Projected Growth (PEG Ratio) (0.520) is also within normal values, averaging (1.190). Dividend Yield (0.031) settles around the average of (0.035) among similar stocks. BMA's P/S Ratio (1.824) is slightly lower than the industry average of (3.738).
The Tickeron Seasonality Score of 19 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 61 (best 1 - 100 worst), indicating fairly steady price growth. BMA’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 97 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a regional bank
Industry RegionalBanks
Advertisement